THE Pharmaceutical Society of Australia has released a new practice support and education package, developed in conjunction with the recently released Professional Practice Standards Version 5 (PPS V5).
Available to all pharmacists, new additions focus on biosimilars, with the project funded by the Federal Department of Health as part of the PBS Access and Sustainability Package including the 6CPA.
PSA practice support and education committee chair, Grant Kardachi, said pharmacists should particularly note the new standard around biosimilar medicines currently approved for use in Australia, including seven items listed on the PBS.
The support package includes a recorded webinar titled Practical considerations associated with biosimilar medicines along with an online biosimilar medicines module.
There are also six case studies covering a range of topics to support the broader implementation of PPS V5 in practice, and an interactive online self-assessment tool.
The tool enables pharmacists to create their own 'practice standard profile' to assess compliance with relevant standards and create an action plan for meeting personal development needs.
PSA national president Shane Jackson urged all pharmacists to familiarise themselves with the standards and "use them to assess and guide their practice to optimise their contribution to improve the health of all Australians"
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Aug 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Aug 17
